When administrated acutely, NP-1 demonstrated its ability to increase adiponectin levels and to ameliorate both hepatic steatosis and insulin resistance in a rat model of diet-induced obesity. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.